CY2004006I1 - Optical isomer of an imidazole derivative - Google Patents

Optical isomer of an imidazole derivative

Info

Publication number
CY2004006I1
CY2004006I1 CY200400006C CY2004006C CY2004006I1 CY 2004006 I1 CY2004006 I1 CY 2004006I1 CY 200400006 C CY200400006 C CY 200400006C CY 2004006 C CY2004006 C CY 2004006C CY 2004006 I1 CY2004006 I1 CY 2004006I1
Authority
CY
Cyprus
Prior art keywords
optical isomer
imidazole derivative
imidazole
derivative
isomer
Prior art date
Application number
CY200400006C
Other languages
English (en)
Other versions
CY2004006I2 (el
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10620775&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2004006(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of CY2004006I1 publication Critical patent/CY2004006I1/el
Publication of CY2004006I2 publication Critical patent/CY2004006I2/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Optical Record Carriers And Manufacture Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CY200400006C 1987-07-16 2004-10-27 Optical isomer of an imidazole derivative CY2004006I2 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8716803A GB2206880B (en) 1987-07-16 1987-07-16 Optical isomers of an imidazole derivative

Publications (2)

Publication Number Publication Date
CY2004006I1 true CY2004006I1 (el) 2009-11-04
CY2004006I2 CY2004006I2 (el) 2009-11-04

Family

ID=10620775

Family Applications (2)

Application Number Title Priority Date Filing Date
CY178795A CY1787A (en) 1987-07-16 1995-10-20 Optical isomer of an imidazole derivative
CY200400006C CY2004006I2 (el) 1987-07-16 2004-10-27 Optical isomer of an imidazole derivative

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY178795A CY1787A (en) 1987-07-16 1995-10-20 Optical isomer of an imidazole derivative

Country Status (29)

Country Link
US (1) US4910214A (el)
EP (1) EP0300652B1 (el)
JP (1) JPH0625138B2 (el)
KR (1) KR940007311B1 (el)
CN (1) CN1022323C (el)
AT (1) ATE71941T1 (el)
AU (1) AU600839B2 (el)
BG (1) BG60473B2 (el)
CA (1) CA1337659C (el)
CY (2) CY1787A (el)
DD (1) DD281807A5 (el)
DE (2) DE10399005I2 (el)
DK (1) DK165788C (el)
ES (1) ES2038757T3 (el)
FI (1) FI95375C (el)
GB (1) GB2206880B (el)
GR (1) GR3003878T3 (el)
HK (1) HK56094A (el)
HU (1) HU198693B (el)
IE (1) IE60456B1 (el)
IL (1) IL87076A0 (el)
LU (1) LU91010I2 (el)
NL (1) NL300117I2 (el)
NO (2) NO170579C (el)
NZ (1) NZ225362A (el)
PT (1) PT88013B (el)
SU (1) SU1648248A3 (el)
UA (1) UA5560A1 (el)
ZA (1) ZA885134B (el)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5120713A (en) * 1990-09-10 1992-06-09 Applied Research Systems Ars Holding N.V. Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
GB9111732D0 (en) * 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
IN187238B (el) * 1995-06-30 2002-03-09 Astra Ab
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
US5866579A (en) * 1997-04-11 1999-02-02 Synaptic Pharmaceutical Corporation Imidazole and imidazoline derivatives and uses thereof
US6716867B1 (en) 1998-04-01 2004-04-06 Orion Corporation Use of dexmedetomidine for ICU sedation
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
EP1223931B1 (en) 1999-10-29 2005-12-14 Orion Corporation Use of a imidazole derivative for the treatment or prevention of hypotension and shock
US6388090B2 (en) * 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
CN101355876B (zh) 2005-11-09 2012-09-05 康宾纳特克斯公司 一种适用于眼部给药的组合物
DK2018160T3 (da) 2006-03-16 2012-02-06 Tris Pharma Inc Modificeret depotformuleringer indeholdende lægemiddel-ionbytterharpikskomplekser
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
EP2370136A4 (en) * 2008-12-01 2015-12-30 Map Pharmaceuticals Inc INHALATIVE RELEASE PROCEDURES AND DEVICES
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN106511273A (zh) * 2009-05-15 2017-03-22 瑞克欧制药有限公司 舌下右美托咪定组合物及其使用方法
CN101671305A (zh) * 2009-09-29 2010-03-17 北京华禧联合科技发展有限公司 一种拆分美托咪定的左旋及右旋对映体的方法
CN102464619A (zh) * 2010-11-17 2012-05-23 桑迪亚医药技术（上海）有限责任公司 一种左旋4-[1-(2,3-二甲基苯基)乙基]-1r-咪唑消旋化方法
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
WO2013069025A1 (en) 2011-11-11 2013-05-16 Neon Laboratories Ltd. "process for the preparation of dexmedetomidine"
SG10201604653TA (en) 2011-12-11 2016-07-28 Recro Pharma Inc Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
ITMI20120311A1 (it) * 2012-02-29 2013-08-30 Edmond Pharma Srl Procedimento per la risoluzione di medetomidina e recupero dell'enantiomero indesiderato
EP2884961B1 (en) 2012-08-15 2019-03-06 Tris Pharma Inc. Methylphenidate extended release chewable tablet
ES2659271T3 (es) * 2012-10-15 2018-03-14 Orion Corporation Método veterinario para aliviar la aversión al ruido
ES2856189T3 (es) 2013-10-07 2021-09-27 Teikoku Pharma Usa Inc Métodos y composiciones para el tratamiento del trastorno de hiperactividad por déficit de atención, ansiedad e insomnio utilizando composiciones transdérmicas de dexmedetomidina
KR101827980B1 (ko) 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
CA2924236C (en) 2013-10-07 2020-01-07 Teikoku Pharma Usa, Inc. Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
CN105175339B (zh) * 2015-10-09 2018-01-16 辰欣药业股份有限公司 一种制备盐酸右美托咪定的方法
US9717796B1 (en) 2016-04-20 2017-08-01 Slypharma, Llc Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
FR3054218B1 (fr) * 2016-07-22 2020-03-06 Universite De Rouen Procede de dedoublement de sels de baclofene
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
CN114671811A (zh) * 2022-04-14 2022-06-28 南京正科医药股份有限公司 一种右美托咪定拆分副产物的外消旋化回收方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
DE3531682A1 (de) * 1985-09-05 1987-03-12 Thomae Gmbh Dr K (+)-6-chlor-5,10-dihydro-5-((1-methyl-4- piperidinyl)acetyl)-11h-dibenzo(b,e)(1,4) diazepin-11-on, seine isolierung und verwendung als arzneimittel

Also Published As

Publication number Publication date
NL300117I2 (nl) 2003-10-01
HUT48218A (en) 1989-05-29
FI95375B (fi) 1995-10-13
DE10399005I2 (de) 2012-06-06
BG60473B2 (bg) 1995-04-28
GR3003878T3 (el) 1993-03-16
NO170579C (no) 1992-11-04
DD281807A5 (de) 1990-08-22
CN1030576A (zh) 1989-01-25
CA1337659C (en) 1995-11-28
HU198693B (en) 1989-11-28
CY1787A (en) 1995-10-20
GB2206880B (en) 1991-04-24
NZ225362A (en) 1990-07-26
NO883155L (no) 1989-01-17
ES2038757T3 (es) 1993-08-01
IE882174L (en) 1989-01-16
NO170579B (no) 1992-07-27
GB8716803D0 (en) 1987-08-19
JPH0625138B2 (ja) 1994-04-06
ATE71941T1 (de) 1992-02-15
DK386288D0 (da) 1988-07-11
AU600839B2 (en) 1990-08-23
LU91010I2 (fr) 2003-06-19
EP0300652B1 (en) 1992-01-22
DK165788C (da) 1993-06-14
NO883155D0 (no) 1988-07-15
SU1648248A3 (ru) 1991-05-07
KR940007311B1 (ko) 1994-08-12
PT88013B (pt) 1995-03-01
DK386288A (da) 1989-01-17
IE60456B1 (en) 1994-07-13
CN1022323C (zh) 1993-10-06
DE10399005I1 (de) 2003-06-05
DK165788B (da) 1993-01-18
FI882819A (fi) 1989-01-17
AU1894188A (en) 1989-01-19
CY2004006I2 (el) 2009-11-04
US4910214A (en) 1990-03-20
FI95375C (fi) 1996-01-25
PT88013A (pt) 1989-06-30
EP0300652A1 (en) 1989-01-25
FI882819A0 (fi) 1988-06-14
HK56094A (en) 1994-06-03
DE3867945D1 (de) 1992-03-05
UA5560A1 (uk) 1994-12-28
ZA885134B (en) 1989-04-26
NL300117I1 (nl) 2003-05-01
JPS6434968A (en) 1989-02-06
IL87076A0 (en) 1988-12-30
GB2206880A (en) 1989-01-18
KR890002030A (ko) 1989-04-07
NO2003004I2 (no) 2005-03-21

Similar Documents

Publication Publication Date Title
CY2004006I1 (el) Optical isomer of an imidazole derivative
LV10614A (lv) 2-anilinopirimidina atvasinajumi
PT87623A (pt) (1h-azol-1-ylmethyl) substituted benzotriazole derivatives
KR890700844A (ko) 반사 망원경
DK554289A (da) Helium-neonlaser
DK328788D0 (da) Fremgangsmaade til fremstilling af et aromatiseringsmiddel
DK600384D0 (da) Optisk forstaerker
DK316589D0 (da) Substituerede azacyclohexylderivater af rifamyciner
DK128988D0 (da) Optisk aktive oxo-isoindolinyl derivater
FI923360A (fi) Foerfarande foer framstaellning av dimetylacetoacetamid
IT1206843B (it) Dispositivo per il collegamento difibre ottiche ad anima singola
IT1138166B (it) Procedimento di racemizzazione di un derivato della tetraidroisochinolina otticamente attivo
DK534587D0 (da) Kompensationsspole
KR850009674U (ko) 광학 픽업
IT1223371B (it) Struttura di occhiali a realizzazione semplificata
BR8706161A (pt) Calibrador laser
KR880017113U (ko) 해태 양식망의 고정장치
LV5777A4 (lv) (1H-azol-1-ilmetil)aizvietota benzotriazola atvasinajumi
KR880017811U (ko) 후렉션 어브서버
KR880017812U (ko) 후렉션 어브서버
DK642188A (da) Timolderivat
KR890012428U (ko) 파마용 로드
DK158804C (da) Ophaeng
SE8802014D0 (sv) Sett for impregnering av lignocellulosamaterial
LV5645A3 (lv) Spogula teleskops